Treatment of locally advanced renal tumors

被引:1
作者
Sanchez Zalabardo, D. [1 ]
Millan Serrano, J. A. [1 ]
De Pablo Cardenas, A. [1 ]
Cuesta Alcala, J. A. [1 ]
机构
[1] Hosp Rema Sofia, Serv Urol, Navarra, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2010年 / 34卷 / 02期
关键词
Locally advanced renal tumor; Treatment; Tyrosine kinase inhibitors; Sunitinib; Sorafenib; Tersirolimus; Bevacizumab; LYMPH-NODE DISSECTION; CELL CARCINOMA; RADICAL NEPHRECTOMY; RANDOMIZED-TRIAL; PHASE-III; THERAPY; CANCER; INVOLVEMENT; INVASION; PROTOCOL;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Locally advanced renal tumors show a high progression rate after surgery. Surgical treatment of renal tumors has some unique characteristics related to involvement of the adrenal gland, vena cava, or regional lymph nodes. Objective: To review the current treatment of locally advanced renal tumors. Materials and methods: A review is made of both the different drugs used and the different therapeutic possibilities in these tumors. Results: Systemic treatment with angiogenesis inhibitors may improve the natural history of these patients. Systemic treatment may be administered before surgery or as an adjuvant to surgical treatment. Early studies showed a decrease in tumor mass when treatment is administered before surgery, but no prospective randomized studies providing adequate evidence for recommending neoadjuvant treatment are available. Conclusions: Availability of systemic treatment with angiogenesis inhibitors may open an important field in the treatment of these tumors in both the neoadjuvant setting and as adjuvants to surgery, but no sufficiently solid scientific evidence as to recommend their use is currently available. Randomized studies with sunitinib and sorafenib will probably suggest the adequate approach to be used when their final results are reported. (C) 2009 AEU. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 50 条
  • [21] Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer
    Puisset, Florent
    Mseddi, Mourad
    Mourey, Loic
    Pouessel, Damien
    Blanchet, Benoit
    Chatelut, Etienne
    Chevreau, Christine
    CANCERS, 2023, 15 (01)
  • [22] Comparison of Different Radiotherapy Techniques for Locally Advanced Pancreatic Tumors
    Gomes, Adriana
    Rodrigues, Darlene
    Ferreira, Brigida C.
    XV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING - MEDICON 2019, 2020, 76 : 1283 - 1290
  • [23] Systematic Review of Adrenalectomy and Lymph Node Dissection in Locally Advanced Renal Cell Carcinoma
    Bekema, Hendrika J.
    MacLennan, Steven
    Imamura, Mari
    Lam, Thomas B. L.
    Stewart, Fiona
    Scott, Neil
    MacLennan, Graeme
    McClinton, Sam
    Griffiths, T. R. Leyshon
    Skolarikos, Andreas
    MacLennan, Sara J.
    Sylvester, Richard
    Ljungberg, Borje
    N'Dow, James
    EUROPEAN UROLOGY, 2013, 64 (05) : 799 - 810
  • [24] Treatment of caval vein thrombosis associated with renal tumors
    Jimenez-Romero, Carlos
    Conde, Maria
    de la Rosa, Federico
    Manrique, Alejandro
    Calvo, Jorge
    Caso, Oscar
    Munoz, Carlos
    Marcacuzco, Alberto
    Justo, Iago
    CIRUGIA ESPANOLA, 2017, 95 (03): : 152 - 159
  • [25] Surgical treatment of locally advanced thyroid cancer
    Roka, Rudolf
    INNOVATIVE SURGICAL SCIENCES, 2020, 5 (1-2): : 27 - 34
  • [26] Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma
    Moreno, Victor Navas
    Valles, Fernando Sebastian
    Vargas, Marcos Lahera
    Marin, Berta Hernandez
    Lopez, Elena Carrillo
    Marazuela, Monica
    de Nova, Jose Luis Munoz
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [27] Treatment of Locally Advanced/Metastatic Colorectal Cancer
    Venook, Alan P.
    Willett, Christopher G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 617 - 621
  • [28] Pazopanib The Newest Tyrosine Kinase Inhibitor for the Treatment of Advanced or Metastatic Renal Cell Carcinoma
    Keisner, Sidney V.
    Shah, Sachin R.
    DRUGS, 2011, 71 (04) : 443 - 454
  • [29] Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer:: a review
    Schoffski, P.
    Dumez, H.
    Clement, P.
    Hoeben, A.
    Prenen, H.
    Wolter, P.
    Joniau, S.
    Roskams, T.
    Van Poppel, H.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1185 - 1196
  • [30] Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma
    Miller, Kurt
    Bergmann, Lothar
    Doehn, Christian
    Gruenwald, Viktor
    Gschwend, Juergen E.
    Ivanyi, Philipp
    Kuczyk, Markus A.
    AKTUELLE UROLOGIE, 2022, 53 (05) : 403 - 415